Skip to main content
. 2006 Oct 27;189(2):620–626. doi: 10.1128/JB.01090-06

TABLE 2.

Primers used in this studya

Name Sequence (5′→3′)
PR-1 5′-GCCGAAGAGAACACAGATTTAGCCCA
PR-2 5′-CCGCACGATGAAGAGCAGAAGTT
PR-3 5′-CAGATCTCTGGAAAACGGGAAAGG
PF-1 5′-AGAGAACACAGATTTAGCCCAGTCGG
PF-2 5′-CCGCACGATGAAGAGCAGAAGTTAT
PF-3 5′-GATCCTGGAAAACGGGAAAGGTTC
TH22-10F1 5′-GAGCATGGTGTAACAGAAGAACAG
TH22-10F2 5′-CTTCGTCCATGTAGTGGTGATTC
TH22-10F3 5′-GGGTTGTACTAATGTCTGTAAACG
TH22-10F4 5′-CTTCGTCCATGTAGTGGTGATT
TH22-10R1 5′-GAATCACCACTACATGGACGAAG
TH22-10R2 5′-CTGTTCTTCTGTTACACCATGCTC
TH22-10R3 5′-AATCACCACTACATGGACGAAG
TH22-10R4 5′-CGTTTACAGACATTAGTACAACCC
TH22-10R5 5′-GTGATCGGCCTGATAACTTCC
TH22-10R6 5′-TTGTCGTGAGCGTCCAATG
TH22-10R7 5′-CATCAAGCAAGTTAACAGGCAAC
TH22-10R8 5′-TCTCCGGAAACACCAGAATG
TH22-10R9 5′-CTCTTCCGCCATTGGTATTC
TH22-10R10 5′-TTCATCTGATGTGTCAGTGCC
TH22-10R11 5′-TGATTGGCCTGAGCTACAGC
TH22-10R12 5′-TGCCGTACCTGCCATTACC
N-1 5′-NGTCGA(G/C)(A/T)GANA(A/T)GAA
N-2 5′-GTNCGA(C/G)(A/T)CANA(A/T)GTT
N-3 5′-(A/T)GTGNAG(A/T)ANCANAGA
P-3 5′-CTCGACGTTGTCACTGAAGCGGGAAG
P-4 5′-AAAGCACGAGGAAGCGGTCAGCCCAT
PCAR-R2 5′-TCAATCTGGCATCGATAACAGGG
PCAR-F2 5′-TGCTGGATCCAGCTTACGTGG
PCAR-F3 5′-GGTTGTACTAATGTCTGTAAACG
PCAR-R3 5′-CGTTTACAGACATTAGTACAACC
a

All primers were purchased from MD Bio Inc., Taipei, Taiwan.